Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov-Dec;23(6):870-883.
doi: 10.1002/pst.2393. Epub 2024 May 6.

Visualizing hypothesis tests in survival analysis under anticipated delayed effects

Affiliations

Visualizing hypothesis tests in survival analysis under anticipated delayed effects

José L Jiménez et al. Pharm Stat. 2024 Nov-Dec.

Abstract

What can be considered an appropriate statistical method for the primary analysis of a randomized clinical trial (RCT) with a time-to-event endpoint when we anticipate non-proportional hazards owing to a delayed effect? This question has been the subject of much recent debate. The standard approach is a log-rank test and/or a Cox proportional hazards model. Alternative methods have been explored in the statistical literature, such as weighted log-rank tests and tests based on the Restricted Mean Survival Time (RMST). While weighted log-rank tests can achieve high power compared to the standard log-rank test, some choices of weights may lead to type-I error inflation under particular conditions. In addition, they are not linked to a mathematically unambiguous summary measure. Test statistics based on the RMST, on the other hand, allow one to investigate the average difference between two survival curves up to a pre-specified time point τ -a mathematically unambiguous summary measure. However, by emphasizing differences prior to τ , such test statistics may not fully capture the benefit of a new treatment in terms of long-term survival. In this article, we introduce a graphical approach for direct comparison of weighted log-rank tests and tests based on the RMST. This new perspective allows a more informed choice of the analysis method, going beyond power and type I error comparison.

Keywords: delayed effects; pseudo‐value; score; survival test; visualization.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. Freidlin B, Korn EL. Methods for accommodating nonproportional hazards in clinical trials: ready for the primary analysis? J Clin Oncol. 2019;37(35):3455.
    1. Freidlin B, Korn EL. Reply to H. Uno et al and B. Huang et al. J Clin Oncol. 2020;38(17):2003‐2004.
    1. Huang B, Wei L‐J, Ludmir EB. Estimating treatment effect as the primary analysis in a comparative study: moving beyond p value. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(17):2001‐2002.
    1. Uno H, Lu T. Is the log‐rank and hazard ratio test/estimation the best approach for primary analysis for all trials? J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(17):2000‐2001.
    1. Lin RS, Lin J, Roychoudhury S, et al. Alternative analysis methods for time to event endpoints under nonproportional hazards: a comparative analysis. Stat Biopharm Res. 2020;12(2):187‐198.

MeSH terms

LinkOut - more resources